Pharmaceutical Preparations · DE · CIK 2100782
Generate Biomedicines uses AI to program novel protein therapeutics for drug discovery and development
Comparable business profile · signals at a glance
In the 90 days to Mar 4, 2026: 6 insiders bought $50.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Nally MichaelChief Executive Officer | Buy | 20,000 | $12.00 | $240K |
| Mar 2, 2026 | Flagship Pioneering Fund Vi, L.P.TenPercentOwner | Buy | 1,562,500 | $16.00 | $25.0M |
| Mar 2, 2026 | Nutritional Health Ltp Fund General Partner LlcTenPercentOwner | Buy | 1,562,500 | $16.00 | $25.0M |
| Mar 2, 2026 | Mendillo Jane LDirector | Buy | 1,500 | $16.00 | $24K |
| Mar 2, 2026 | Silvers JasonPresident & CFO | Buy | 1,000 | $16.00 | $16K |
| Mar 2, 2026 | Silvers JasonPresident & CFO | Buy | 500 | $16.00 | $8K |
| Mar 2, 2026 | Grous BethChief People Officer | Buy | 300 | $16.00 | $5K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗